Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine in Advanced-Stage Myelodysplastic Syndromes
NCT00260065Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of decitabine in myelodysplastic syndrome (MDS), sponsored by Eisai Co., Ltd.. Started May 2005; status: completed.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00260065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260065.